Xylem shareholders back 2026 directors and plans
Xylem Inc. reported the results of its 2026 Annual Meeting of Shareholders.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xylem Inc. reported the results of its 2026 Annual Meeting of Shareholders. A total of 212,209,479 shares were represented, equal to 88.12% of common stock outstanding on March 19, 2026, meaning a high level of shareholder participation.
Shareholders elected nine directors, with each nominee receiving a strong majority of votes cast. For example, Earl R. Ellis received 199,588,485 votes for and 1,615,787 against, while all other nominees similarly achieved clear approval despite some variation in support levels.
Investors also ratified Deloitte & Touche LLP as independent auditor for 2026 with 205,386,746 votes for and 6,164,834 against. The advisory vote on named executive officer compensation passed with 176,623,615 votes for and 24,442,685 against. Shareholders further approved implementation of the Xylem Inc. 2026 Employee Stock Purchase Plan, with 200,869,123 votes for and 313,939 against.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
advisory vote financial
named executive officers financial
independent registered public accounting firm financial
Employee Stock Purchase Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were all Xylem (XYL) director nominees elected at the 2026 Annual Meeting?
Was Deloitte & Touche LLP ratified as Xylem (XYL) auditor for 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.